{7 (siponimod 0.25 MG Oral Tablet) } Pack

RxCUI: 2594796
RxNorm name: {7 (siponimod 0.25 MG Oral Tablet) } Pack
Display name: {7 (siponimod 0.25 MG Oral Tablet) } Pack
Full name: {7 (siponimod 0.25 MG Oral Tablet) } Pack
Term type: GPCK
Status: DailyMed mapping
Updated: 2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
MAYZENT	SIPONIMOD	Novartis Pharmaceuticals Corporation	44492772-5aed-4627-bd85-e8e89f308bb3	2026-06-30	Warnings, Adverse reactions	Exact identifier rxcui: 2594796

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
44492772-5aed-4627-bd85-e8e89f308bb3	{7 (siponimod 0.25 MG Oral Tablet) } Pack	GPCK	16	These highlights do not include all the information needed to use MAYZENT safely and effectively. See full prescribing information for MAYZENT. MAYZENT ® (siponimod) tablets, for oral use Initial U.S. Approval: 2019	20250821
44492772-5aed-4627-bd85-e8e89f308bb3	siponimod 0.25 MG (7) Oral Tablet Pack	SY	16	These highlights do not include all the information needed to use MAYZENT safely and effectively. See full prescribing information for MAYZENT. MAYZENT ® (siponimod) tablets, for oral use Initial U.S. Approval: 2019	20250821
44492772-5aed-4627-bd85-e8e89f308bb3	siponimod 0.25 MG (7) Oral Tablet Pack	PSN	16	These highlights do not include all the information needed to use MAYZENT safely and effectively. See full prescribing information for MAYZENT. MAYZENT ® (siponimod) tablets, for oral use Initial U.S. Approval: 2019	20250821